Thioflavin T templates amyloid β(1-40) conformation and aggregation pathway

Maria Giovanna Di Carlo1, Velia Minicozzi2, Vito Foderà3

  • 1Dipartimento di Fisica e Chimica, Università degli Studi di Palermo, Via Archirafi 36, I-90123 Palermo, Italy.

Biophysical Chemistry
|June 24, 2015
PubMed

Insights

The fluorescent dye Thioflavin T (ThT), commonly used to study Alzheimer's disease (AD) progression, unexpectedly accelerates Aβ(1-40) peptide aggregation. This highlights the need for label-free methods for accurate amyloid studies.

Area of Science:

  • Biochemistry
  • Neuroscience
  • Molecular Biology

Background:

  • Alzheimer's disease (AD) is linked to amyloid-beta (Aβ) peptide aggregation.
  • Understanding Aβ(1-40) assembly is crucial for developing AD therapies.
  • Fluorescent probes like Thioflavin T (ThT) are widely used to monitor amyloid formation.

Purpose of the Study:

  • To investigate the impact of Thioflavin T (ThT) on Aβ(1-40) conformation, stability, and aggregation.
  • To elucidate the molecular mechanisms by which ThT influences Aβ(1-40) self-assembly.
  • To assess the reliability of ThT as a probe in amyloid research.

Main Methods:

  • Experimental techniques combined with Molecular Dynamics (MD) simulations.
  • Analysis of Aβ(1-40) peptide conformation and stability in the presence of ThT.
  • Investigating ThT-induced changes in supramolecular assembly and aggregation pathways.

Main Results:

  • Thioflavin T (ThT) alters Aβ(1-40) peptide conformation, inducing a rigid, partially-folded state.
  • ThT promotes specific supramolecular associations that enhance aggregation propensity.
  • The presence of ThT shifts the equilibrium towards aggregation-prone peptide species.

Conclusions:

  • ThT is not an inert probe and can artifactually accelerate Aβ(1-40) aggregation.
  • Findings suggest strategies to control or block Aβ aggregation by manipulating peptide conformation.
  • Emphasizes the critical need for label-free techniques for unbiased studies of Aβ aggregation.